Sunesis Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

SNSS 1.71 +0.28 (19.58%)
price chart
Ahead of the Bell: Sunesis Pharma shares sink
Sunesis said it will seek marketing approval from European regulators and also will meet with the U.S. Food and Drug Administration to determine the "appropriate regulatory path forward.
An Insight Into Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)  Inside Trade
Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin ...  MarketWatch
Related articles »  
Short Interest: JDS Uniphase Corporation (JDSU), Adobe Systems (ADBE ...
Recent short interest data for the 9/30/2014 settlement date shows an increase in short interest for shares of Sunesis Pharmaceuticals, Inc. (SNSS). As of September 30, the short interest for the biopharmaceutical company totaled 10,826,791 shares, ...
Sunesis Pharmaceuticals Inc. (SNSS) Hits New 52-week Low During October 10 ...
Sunesis Pharmaceuticals Inc. (SNSS) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $1.22, Sunesis Pharmaceuticals Inc. dropped to $1.05 for a new 52-week low. By the closing bell, the company's ...
Related articles »  
Momentum Stocks: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), American ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) saw a mixed track record, when it comes to anticipates revisions of two increases and one decrease in the previous third trading session.
Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo
Shares of Sunesis Pharmaceuticals, Inc. (SNSS - Snapshot Report) plunged significantly after the company announced that its phase III trial, VALOR, failed to meet its primary endpoint.
Hot Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Sunesis ...
Lakeway, NY - (MARKET NEWS CALL) - 10/22/2014�, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Hot Watch List : Verizon Communications Inc. (NYSE:VZ), Sunesis ...
Company weekly performance is 0.23% while its quarterly performance stands at -3.85%. Verizon Communications Inc. (NYSE:VZ) is -8.63% away from its 52 week high.
News Recap: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Hemispherx ...  Market News Call
Related articles »  
The Zacks Analyst Blog Highlights: Sunesis Pharmaceuticals, Chimerix ...
Last week, companies like Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS-Free Report) and Chimerix, Inc. (Nasdaq: CMRX-Free Report) were in the news due to pipeline updates.
Related articles »  
Stocks responding to negative shocks: Sunesis Pharmaceuticals, Inc. (NASDAQ ...
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) sank 78.01% to new low on Monday after the drug developer said its treatment for an aggressive form of blood cancer failed to meet its main goal in late-stage testing.
Related articles »  
Sunesis Pharmaceuticals Inc. (SNSS) Jumps 8.49% on October 14
Sunesis Pharmaceuticals Inc. (SNSS) was among the biggest gainers on the Russell 2000 for October 14 as the stock popped 8.49% to $1.15, representing a gain of $0.09 per share.
Related articles »